The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis

被引:19
作者
Zhao, Ting C. [1 ]
Wang, Zhengke [2 ]
Zhao, Tina Y. [3 ]
机构
[1] Brown Univ, Rhode Isl Hosp, Dept Surg & Plast Surg, Providence, RI 02903 USA
[2] Brown Univ, Sch Med, Roger Williams Med Ctr, Dept Surg, 50 Maude St, Providence, RI 02908 USA
[3] Univ Rochester, Sch Med & Dent, Rochester, NY USA
关键词
Histone deacetylase; Epigenetics; Acetylation; Deacetylation; Cardiovascular disease; Vascular smooth muscle cell; Endothelial; Atherosclerosis; SMOOTH-MUSCLE-CELLS; HUMAN ENDOTHELIAL-CELLS; GENE-EXPRESSION; KINASE-II; SIRT1; INHIBITION; ANGIOGENESIS; PHOSPHORYLATION; DIFFERENTIATION; OVEREXPRESSION;
D O I
10.1016/j.atherosclerosis.2020.04.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases are the leading cause of deaths in the world. Endothelial dysfunction followed by in- flammation of the vessel wall leads to atherosclerotic lesion formation that causes ischemic heart and myocardial hypertrophy, which ultimately progress into cardiac dysfunction and failure. Histone deacetylases (HDACs) have been recognized to play crucial roles in cardiovascular disease, particularly in the epigenetic regulation of gene transcription in response to a variety of stresses. The unique nature of HDAC regulation includes that HDACs form a complex co -regulatory network with other transcription factors, deacetylate histones and non-histone proteins to facilitate the regulatory mechanism of the vascular system. The selective HDAC inhibitors are con- sidered as the most promising target in cardiovascular disease, especially for preventing cardiac hypertrophy. In this review, we discuss our present knowledge of the cellular and molecular basis of HDACs in mediating the biological function of vascular cells and related pharmacologic interventions in vascular disease.
引用
收藏
页码:36 / 42
页数:7
相关论文
共 91 条
[1]   Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke [J].
Bellenguez, Celine ;
Bevan, Steve ;
Gschwendtner, Andreas ;
Spencer, Chris C. A. ;
Burgess, Annette I. ;
Pirinen, Matti ;
Jackson, Caroline A. ;
Traylor, Matthew ;
Strange, Amy ;
Su, Zhan ;
Band, Gavin ;
Syme, Paul D. ;
Malik, Rainer ;
Pera, Joanna ;
Norrving, Bo ;
Lemmens, Robin ;
Freeman, Colin ;
Schanz, Renata ;
James, Tom ;
Poole, Deborah ;
Murphy, Lee ;
Segal, Helen ;
Cortellini, Lynelle ;
Cheng, Yu-Ching ;
Woo, Daniel ;
Nalls, Michael A. ;
Mueller-Myhsok, Bertram ;
Meisinger, Christa ;
Seedorf, Udo ;
Ross-Adams, Helen ;
Boonen, Steven ;
Wloch-Kopec, Dorota ;
Valant, Valerie ;
Slark, Julia ;
Furie, Karen ;
Delavaran, Hossein ;
Langford, Cordelia ;
Deloukas, Panos ;
Edkins, Sarah ;
Hunt, Sarah ;
Gray, Emma ;
Dronov, Serge ;
Peltonen, Leena ;
Gretarsdottir, Solveig ;
Thorleifsson, Gudmar ;
Thorsteinsdottir, Unnur ;
Stefansson, Kari ;
Boncoraglio, Giorgio B. ;
Parati, Eugenio A. ;
Attia, John .
NATURE GENETICS, 2012, 44 (03) :328-U141
[2]   The Sir2 family of protein deacetylases [J].
Blander, G ;
Guarente, L .
ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :417-435
[3]  
Boyle J. J., 2005, Current Vascular Pharmacology, V3, P63, DOI 10.2174/1570161052773861
[4]   Histone Deacetylase 9 Represses Cholesterol Efflux and Alternatively Activated Macrophages in Atherosclerosis Development [J].
Cao, Qiang ;
Rong, Shunxing ;
Repa, Joyce J. ;
St Clair, Richard ;
Parks, John S. ;
Mishra, Nilamadhab .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (09) :1871-1879
[5]   SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence [J].
Cardus, Anna ;
Uryga, Anna K. ;
Walters, Gareth ;
Erusalimsky, Jorge D. .
CARDIOVASCULAR RESEARCH, 2013, 97 (03) :571-579
[6]  
Carter Angela M, 2005, Diab Vasc Dis Res, V2, P113, DOI 10.3132/dvdr.2005.018
[7]   Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10 [J].
Chang, Shurong ;
Young, Bryan D. ;
Li, Shijie ;
Qi, Xiaoxia ;
Richardson, James A. ;
Olson, Eric N. .
CELL, 2006, 126 (02) :321-334
[8]   The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase [J].
Chen, Jihui ;
Zhang, Jian ;
Shaik, Noor F. ;
Yi, Bing ;
Wei, Xin ;
Yang, Xiao-Feng ;
Naik, Ulhas P. ;
Summer, Ross ;
Yan, Guijun ;
Xu, Xinyun ;
Sun, Jianxin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (51) :19565-19576
[9]   Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation [J].
Chi, Zhexi ;
Byeon, Hye-Eun ;
Seo, Eunjeong ;
Nguyen, Quynh-Anh T. ;
Lee, Wonbeom ;
Jeong, Yunyong ;
Choi, Juyong ;
Pandey, Deepesh ;
Berkowitz, Dan E. ;
Kim, Jae Hyung ;
Lee, Sang Yoon .
PHARMACOLOGICAL RESEARCH, 2019, 146
[10]   Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension [J].
Choi, Sin Young ;
Kee, Hae Jin ;
Sun, Simei ;
Seok, Young Mi ;
Ryu, Yuhee ;
Kim, Gwi Ran ;
Kee, Seung-Jung ;
Pflieger, Marc ;
Kurz, Thomas ;
Kassack, Matthias U. ;
Jeong, Myung Ho .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (04) :2801-2812